pennystocktracker
08-12-2009, 11:31 AM
GREAT…..Anadys Pharmaceuticals, Inc (NASDAQ:ANDS) climbed over 18.4% to $2.84 on a traded volume of 564k shares. The 52 week range for the stock is $8.43 and $1.44. Today (August 11, 2009), Anadys Pharmaceuticals, Inc. announced viral load data for the final cohort of hepatitis C patients in a Phase I clinical trial of ANA773, the Company's oral inducer of endogenous interferons that acts via the toll-like receptor 7 (TLR7) pathway…………
You can also check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!
You can also check out LiquidTycoon dot com bcuz they have a summary report on the company...very informative site!